NAC is a key supporter of Glutathione, providing the energy it needs to fight off free radicals and promote overall health
GHK-Cu/Epitalon is given as a subcutaneous injection, often in cycles, on a provider-determined schedule
As per the data collected by the National Center for Health Statistics, it was projected that in the USA, 1,958,310 new cancer cases and 609,820 cancer deaths would occur in 2023

Sleep and recovery: Deeper, more restorative sleep becomes a reliable pattern rather than an occasional effect Post-exercise recovery improves less soreness, faster return to baseline Minor soft tissue aches (old nagging injuries) may begin to feel better Body composition (early signals): Skin quality begins to improve increased hydration and elasticity from GH-driven collagen synthesis Subtle reduction in subcutaneous water retention, particularly around the midsection Appetite patterns shift some users report increased hunger (GH is a counterregulatory hormone), others report better appetite regulation Energy and mood: More consistent energy levels through the day Improved sense of well-being GH influences neurotransmitter function and this often manifests as a subtle mood elevation DAC vs no-DAC difference: By week 2-4, DAC users on a 1-2x/week schedule have accumulated sustained IGF-1 elevation

These studies will help define standardized dosing protocols and refine patient selection criteria to maximize benefits